Pediatric Leukemia/Lymphoma

Healio spoke with Gwen Nichols, MD, to discuss how to approach CML treatment in pediatric patients.

The FDA expanded the approval of bosutinib to include treatment of certain children with chronic myelogenous leukemia.

NEW ORLEANS — Cumulative anesthesia exposure appeared associated with impairments in neurocognitive function among children with high-risk acute lymphoblastic leukemia, according to study results presented at ASH Annual Meeting and Exposition.

In this video, Rayne Rouce, MD, discusses the top chimeric antigen receptor T-cell therapy-related presentations at ASH, including several presentations targeting T-cell malignancies, which she said is exciting.

The addition of rituximab to standard lymphomes malins B chemotherapy improved EFS and OS among a subset of pediatric patients with non-Hodgkin lymphoma, according to study results published in The New England Journal of Medicine.